Dyadic Applied BioSolutions Partners with IBT Bioservices for Commercial Distribution of Recombinant Protein Products

Dyadic Applied BioSolutions has partnered with IBT Bioservices to commercialize recombinant protein products. The initial products include DNase I and transferrin for research-use-only applications. This agreement supports Dyadic's transition to commercial product sales and enables its products to reach the market through established global distribution channels. Dyadic believes this agreement reflects progress in advancing from platform development to commercial execution and supports its long-term objective of translating its technology and manufacturing capabilities into scalable revenue opportunities.